176 related articles for article (PubMed ID: 38751648)
1. Hydroxytyrosol Linoleoyl Ether Ameliorates Metabolic-Associated Fatty Liver Disease Symptoms in Obese Zucker Rats.
Tovar R; de Ceglia M; Rodríguez-Pozo M; Vargas A; Gavito A; Suárez J; Boronat A; de la Torre R; de Fonseca FR; Baixeras E; Decara J
ACS Pharmacol Transl Sci; 2024 May; 7(5):1571-1583. PubMed ID: 38751648
[TBL] [Abstract][Full Text] [Related]
2. Novel effects of the cannabinoid inverse agonist AM 251 on parameters related to metabolic syndrome in obese Zucker rats.
Merroun I; Sánchez-González C; Martínez R; López-Chaves C; Porres JM; Aranda P; Llopis J; Galisteo M; Zarzuelo A; Errami M; López-Jurado M
Metabolism; 2013 Nov; 62(11):1641-50. PubMed ID: 23932644
[TBL] [Abstract][Full Text] [Related]
3. Treatment with a novel oleic-acid-dihydroxyamphetamine conjugation ameliorates non-alcoholic fatty liver disease in obese Zucker rats.
Decara JM; Pavón FJ; Suárez J; Romero-Cuevas M; Baixeras E; Vázquez M; Rivera P; Gavito AL; Almeida B; Joglar J; de la Torre R; Rodríguez de Fonseca F; Serrano A
Dis Model Mech; 2015 Oct; 8(10):1213-25. PubMed ID: 26438694
[TBL] [Abstract][Full Text] [Related]
4. Effects of a combined intervention with a lentil protein hydrolysate and a mixed training protocol on the lipid metabolism and hepatic markers of NAFLD in Zucker rats.
Martínez R; Kapravelou G; Donaire A; Lopez-Chaves C; Arrebola F; Galisteo M; Cantarero S; Aranda P; Porres JM; López-Jurado M
Food Funct; 2018 Feb; 9(2):830-850. PubMed ID: 29364302
[TBL] [Abstract][Full Text] [Related]
5. Tesaglitazar, a dual PPAR{alpha}/{gamma} agonist, ameliorates glucose and lipid intolerance in obese Zucker rats.
Oakes ND; Thalén P; Hultstrand T; Jacinto S; Camejo G; Wallin B; Ljung B
Am J Physiol Regul Integr Comp Physiol; 2005 Oct; 289(4):R938-46. PubMed ID: 16183630
[TBL] [Abstract][Full Text] [Related]
6. Dietary walnut oil modulates liver steatosis in the obese Zucker rat.
Fink A; Rüfer CE; Le Grandois J; Roth A; Aoude-Werner D; Marchioni E; Bub A; Barth SW
Eur J Nutr; 2014; 53(2):645-60. PubMed ID: 23942585
[TBL] [Abstract][Full Text] [Related]
7. Green tea polyphenols ameliorate non-alcoholic fatty liver disease through upregulating AMPK activation in high fat fed Zucker fatty rats.
Tan Y; Kim J; Cheng J; Ong M; Lao WG; Jin XL; Lin YG; Xiao L; Zhu XQ; Qu XQ
World J Gastroenterol; 2017 Jun; 23(21):3805-3814. PubMed ID: 28638220
[TBL] [Abstract][Full Text] [Related]
8. The cannabinoid CB1 receptor antagonist SR141716A (Rimonabant) enhances the metabolic benefits of long-term treatment with oleoylethanolamide in Zucker rats.
Serrano A; Del Arco I; Javier Pavón F; Macías M; Perez-Valero V; Rodríguez de Fonseca F
Neuropharmacology; 2008 Jan; 54(1):226-34. PubMed ID: 17467748
[TBL] [Abstract][Full Text] [Related]
9. Pentose phosphate pathway activity parallels lipogenesis but not antioxidant processes in rat liver.
Jin ES; Lee MH; Murphy RE; Malloy CR
Am J Physiol Endocrinol Metab; 2018 Jun; 314(6):E543-E551. PubMed ID: 29351478
[TBL] [Abstract][Full Text] [Related]
10. Abnormal polyunsaturated lipid metabolism in the obese Zucker rat, with partial metabolic correction by gamma-linolenic acid administration.
Phinney SD; Tang AB; Thurmond DC; Nakamura MT; Stern JS
Metabolism; 1993 Sep; 42(9):1127-40. PubMed ID: 8412765
[TBL] [Abstract][Full Text] [Related]
11. Aerobic interval exercise improves parameters of nonalcoholic fatty liver disease (NAFLD) and other alterations of metabolic syndrome in obese Zucker rats.
Kapravelou G; Martínez R; Andrade AM; Nebot E; Camiletti-Moirón D; Aparicio VA; Lopez-Jurado M; Aranda P; Arrebola F; Fernandez-Segura E; Bermano G; Goua M; Galisteo M; Porres JM
Appl Physiol Nutr Metab; 2015 Dec; 40(12):1242-52. PubMed ID: 26509584
[TBL] [Abstract][Full Text] [Related]
12. A new NRF2 activator for the treatment of human metabolic dysfunction-associated fatty liver disease.
Hammoutene A; Laouirem S; Albuquerque M; Colnot N; Brzustowski A; Valla D; Provost N; Delerive P; Paradis V;
JHEP Rep; 2023 Oct; 5(10):100845. PubMed ID: 37663119
[TBL] [Abstract][Full Text] [Related]
13. Diazoxide enhances basal metabolic rate and fat oxidation in obese Zucker rats.
Alemzadeh R; Karlstad MD; Tushaus K; Buchholz M
Metabolism; 2008 Nov; 57(11):1597-607. PubMed ID: 18940400
[TBL] [Abstract][Full Text] [Related]
14. Gut Akkermansia muciniphila ameliorates metabolic dysfunction-associated fatty liver disease by regulating the metabolism of L-aspartate via gut-liver axis.
Rao Y; Kuang Z; Li C; Guo S; Xu Y; Zhao D; Hu Y; Song B; Jiang Z; Ge Z; Liu X; Li C; Chen S; Ye J; Huang Z; Lu Y
Gut Microbes; 2021; 13(1):1-19. PubMed ID: 34030573
[TBL] [Abstract][Full Text] [Related]
15. Crocin ameliorates hepatic steatosis through activation of AMPK signaling in db/db mice.
Luo L; Fang K; Dan X; Gu M
Lipids Health Dis; 2019 Jan; 18(1):11. PubMed ID: 30621686
[TBL] [Abstract][Full Text] [Related]
16. Diazoxide attenuates insulin secretion and hepatic lipogenesis in zucker diabetic fatty rats.
Alemzadeh R; Tushaus K
Med Sci Monit; 2005 Dec; 11(12):BR439-48. PubMed ID: 16319780
[TBL] [Abstract][Full Text] [Related]
17. Impaired long-chain fatty acid oxidation and contractile dysfunction in the obese Zucker rat heart.
Young ME; Guthrie PH; Razeghi P; Leighton B; Abbasi S; Patil S; Youker KA; Taegtmeyer H
Diabetes; 2002 Aug; 51(8):2587-95. PubMed ID: 12145175
[TBL] [Abstract][Full Text] [Related]
18. Cinnamon could improve hepatic steatosis caused by a high-fat diet via enhancing hepatic beta-oxidation and inhibiting hepatic lipogenesis, oxidative damage, and inflammation in male rats.
Li B; Li J; Hu S
J Food Biochem; 2022 Jun; 46(6):e14077. PubMed ID: 35246859
[TBL] [Abstract][Full Text] [Related]
19. Oleoylethanolamide, an endogenous PPAR-alpha agonist, lowers body weight and hyperlipidemia in obese rats.
Fu J; Oveisi F; Gaetani S; Lin E; Piomelli D
Neuropharmacology; 2005 Jun; 48(8):1147-53. PubMed ID: 15910890
[TBL] [Abstract][Full Text] [Related]
20. A dynamic association between myosteatosis and liver stiffness: Results from a prospective interventional study in obese patients.
Nachit M; Lanthier N; Rodriguez J; Neyrinck AM; Cani PD; Bindels LB; Hiel S; Pachikian BD; Trefois P; Thissen JP; Delzenne NM
JHEP Rep; 2021 Aug; 3(4):100323. PubMed ID: 34355155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
